CorMedix (CRMD) PT Raised to $14 at RBC Capital

April 27, 2026 1:20 PM

RBC Capital analyst Leonid Timashev raised the price target on CorMedix (NASDAQ: CRMD) to $14.00 (from $13.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found